Nuvalent, Inc. - Class A Common Stock (NUVL)
123.25
+34.76 (39.28%)
NASDAQ· Last Trade: Jun 9th, 6:31 PM EDT
BALA CYNWYD, Pa., June 09, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · June 9, 2026
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Nuvalent, Inc. (NASDAQ: NUVL) to GSK plc for $124.00 per share in cash.
By Halper Sadeh LLC · Via Business Wire · June 9, 2026